Zobrazeno 1 - 4
of 4
pro vyhledávání: '"39"'
Autor:
Naoyuki Nogami, Shunta Mori, Yumi Asakura, Daijiro Harada, Kenji Takata, Takayuki Ohno, Satoko Moriki, Toshiyuki Kozuki, Yoshika Takechi
Publikováno v:
Anticancer Research. 39:4987-4993
Background/aim For immune checkpoint inhibitor (ICI)-pretreated patients, docetaxel and ramucirumab (DOC+RAM) combination therapy may be more effective compared to patients not receiving ICI treatment. Patients and methods From June 2013 to July 2018
Autor:
Hideki Muramatsu, Hirotsugu Ohkubo, Satoshi Fukuda, Akio Niimi, Makoto Nakao, Takehiro Uemura, Ken Maeno, Yutaka Ito, Yoshihiro Kanemitsu, Ryota Kurowaka, Kazuki Sone, Osamu Takakuwa, Yusuke Kagawa, Tetsuya Oguri, Masaya Takemura, Hiromi Furuta, Hidefumi Sato
Publikováno v:
Anticancer research. 37(2)
BACKGROUND Pretreatment serum tumor marker levels predict outcome in non-small cell lung cancer (NSCLC). However, little is known about the clinical value of such measurements for patients treated with pemetrexed plus a platinum-derivative. PATIENTS
Autor:
Takehito, Shukuya, Toshiaki, Takahashi, Hideyuki, Harada, Hiroaki, Akamatsu, Chikara, Sakaguchi, Hisao, Imai, Akira, Ono, Yukiko, Nakamura, Asuka, Tsuya, Hirotsugu, Kenmotsu, Tateaki, Naito, Haruyasu, Murakami, Masahiro, Endo, Kazuhisa, Takahashi, Nobuyuki, Yamamoto
Publikováno v:
Anticancer research. 32(2)
Based on the results of phase I/II studies, S-1 plus cisplatin (CDDP) and vinorelbine (VNR) plus CDDP are commonly used chemoradiotherapeutic regimens for the treatment of non-small cell lung cancer(NSCCLC) in Japan. However, there have been no studi
Publikováno v:
Anticancer research. 20(3B)
The relationship between preoperative serum carcinoembryonic antigen (CEA) level and treatment outcome for 39 clinical-stage I patients with surgically resected non-small-cell lung cancer (NSCLC) was retrospectively studied. Serum CEA levels were mea